证券记录 · 已归档季度
ZLAB
Zai Lab Limited · Healthcare · Biotechnology
12被追踪持有人
0Δ持有人
16.81M持有股份
$440.22M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -17.9% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 40 | -10 | 13.04M | $247.56M | +1 | −11 |
| Q1 2026 | 51 | -8 | 9.02M | $169.34M | +7 | −15 |
| Q4 2025 | 58 | 0 | 14.32M | $252.66M | +1 | −1 |
| Q3 2025 | 13 | -2 | 15.41M | $522.27M | — | −2 |
| Q2 2025 | 12 | -2 | 15.57M | $544.48M | — | −2 |
| Q1 2025 | 12 | 0 | 13.16M | $475.75M | — | — |
| Q4 2024 | 12 | 0 | 16.81M | $440.22M | +1 | −1 |
| Q3 2024 | 11 | +1 | 20.32M | $490.64M | +1 | — |
| Q2 2024 | 10 | — | 17.23M | $298.54M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 6.66M | -21.1% | $174.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Capital World Investors ✦ | 6.43M | 0.0% | $168.49M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 2.35M | +30.4% | $61.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 2.35M | +30.4% | $61.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 288.99K | 新增 | $7.57M | 0.0% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 288.99K | 新增 | $7.57M | 0.0% | New | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 283.60K | +2006.4% | $7.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 187.80K | +112.7% | $4.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 180.05K | -86.5% | $4.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 180.05K | -86.5% | $4.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (被动) | 140.81K | — | $3.69M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 123.39K | -10.8% | $3.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 73.41K | +729.6% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 55.52K | +27.3% | $1.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 29.76K | -56.2% | $779,336 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $7.57M | 0.0% |
| Marshall Wace | $7.57M | 0.0% |
已清仓
| Viking Global Investors | $47.07M | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 97 持有人, 28.24M 股份, $515.77M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Chen Yajing
Officer · 260 股 · $7,020
Aug 12
Lis William
Director · 8.51K 股 · $212,650
Aug 11
Chen Yajing
Officer · 619 股 · $15,475
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jun 11
SC 13G — TCG Crossover GP II, LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据